Meizhou City People's Hospital
In research, Meizhou City People's Hospital stands highest in Medicine (#3,180 of 10,443 worldwide), Health Sciences (#3,731 of 11,982 worldwide) and Life Sciences (#3,254 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 6.5× its share of world research.
- World rank, 2022–2025
- #6,808 of 28,054 · #15,669 all time
- Rank in China
- #1,405 of 3,058
- Research works
- 1.5k ▼ 37% vs 2013–17
- Citations
- 5.4k 3.7 per fractional work
- Top-10% rate
- 14.4% record average 16.5%
- Open access
- 36% world 28%
What is Meizhou City People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,180 of 10,443 | 14.0% | 280 | #6268 | |
| Health SciencesDomain | #3,731 of 11,982 | 13.8% | 291 | #7700 | |
| Life SciencesDomain | #3,254 of 7,800 | 17.3% | 94 | #7531 |
Each strip is that field’s whole ranked pool, with the notch where Meizhou City People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#6,268 #3,180
- Health Sciences#7,700 #3,731
- Life Sciences#7,531 #3,254
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Meizhou City People's Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 6.5× the share of its output that it takes of world research.
- OncologySubfield · 30.1 works6.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.0×. Every wedge is a field page.
- Immunology and Microbiology 4.0×
- Medicine 3.5×
- Pharmacology, Toxicology and Pharmaceutics 2.8×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Nursing 1.7×
- Neuroscience 1.5×
- Veterinary 0.6×
- Health Professions 0.6×
- Dentistry 0.4×
- Agricultural and Biological Sciences 0.2×
- Psychology 0.2×
- Physics and Astronomy 0.2×
- Chemistry 0.2×
- Engineering 0.2×
- Environmental Science 0.1×
- Arts and Humanities 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Mathematics 0.1×
- Business, Management and Accounting 0.1×
- Social Sciences 0.1×
- Energy 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Meizhou City People's Hospital?
Ranked on the composite score, Heming Wu lead among researchers whose main affiliation is Meizhou City People's Hospital.
- 1 Heming Wu China · #1,376,528 worldwide 28 citations · 18 works
Which keywords describe research at Meizhou City People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Tumor Microenvironment, Epidemiology, Chemotherapy, Oxidative Stress, Clinical Practice Guidelines and Metastasis.
- Survival
- Systemic Inflammatory Response
- Genetic Polymorphisms
- Critical Care
- Sepsis
- Insulin Resistance
- Thrombosis
- GPX4
- Prognostic Markers
- Surgical Management
- Immunotherapy
- Guidelines
- Quality of Life
- Metabolic Syndrome
- Diagnosis
- Metastasis
- Management
- Chemotherapy
- Oxidative Stress
- Epidemiology
- Inflammation
- Cancer
- Tumor Microenvironment
- Clinical Practice Guidelines
- Cardiovascular Disease
- Treatment
- Gene Expression
- Biomarkers
- Cell Death
- Immunity
- Prognostic Factors
- Lipid Peroxidation
- Ferroptosis
- Neoadjuvant Therapy
- Complications
- Prognosis
- Survival Analysis
- Platelets
- Neutrophil-to-Lymphocyte Ratio
- Hepatocellular Carcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation44▲ 5.1×63 topics
- Epidemiology41▲ 2.5×77 topics
- Cancer39▲ 7.0×36 topics
- Oxidative Stress26▲ 3.9×34 topics
- Tumor Microenvironment25▲ 14×7 topics
- Chemotherapy21▲ 7.2×22 topics
- Clinical Practice Guidelines18▲ 7.9×13 topics
- Management17▲ 5.2×16 topics
- Cardiovascular Disease17▲ 3.6×25 topics
- Metastasis16▲ 11×12 topics
- Treatment16▲ 3.2×27 topics
- Diagnosis16▲ 4.1×24 topics
- Gene Expression16▲ 6.3×9 topics
- Metabolic Syndrome15▲ 4.4×18 topics
- Biomarkers14▲ 5.1×13 topics
- Quality of Life13▲ 2.2×22 topics
- Cell Death12▲ 12×5 topics
- Guidelines12▲ 6.1×12 topics
- Immunity12▲ 6.9×9 topics
- Immunotherapy11▲ 3.7×15 topics
- Prognostic Factors11▲ 6.0×13 topics
- Surgical Management9▲ 5.5×15 topics
- Lipid Peroxidation9▲ 21×2 topics
- Prognostic Markers9▲ 21×3 topics
- Ferroptosis9▲ 28×1 topic
- GPX49▲ 28×1 topic
- Neoadjuvant Therapy9▲ 9.2×5 topics
- Thrombosis9▲ 7.7×5 topics
- Complications9▲ 4.3×12 topics
- Insulin Resistance9▲ 4.6×9 topics
- Prognosis8▲ 5.8×6 topics
- Sepsis8▲ 11×5 topics
- Survival Analysis8▲ 6.9×5 topics
- Critical Care8▲ 8.0×5 topics
- Platelets7▲ 26×2 topics
- Genetic Polymorphisms7▲ 31×3 topics
- Neutrophil-to-Lymphocyte Ratio7▲ 42×1 topic
- Systemic Inflammatory Response7▲ 42×1 topic
- Hepatocellular Carcinoma7▲ 7.8×3 topics
- Survival7▲ 12×3 topics
Which research topics does Meizhou City People's Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Inflammatory Biomarkers in Disease Prognosis, Cancer Immunotherapy and Biomarkers and Thyroid Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 9 works
- 2 Inflammatory Biomarkers in Disease Prognosis Oncology 7 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 6 works
- 4 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 4 works
- 5 Sepsis Diagnosis and Treatment Epidemiology 4 works
- 6 Cancer-related molecular mechanisms research Cancer Research 4 works
- 7 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 4 works
- 8 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 4 works
- 9 Uterine Myomas and Treatments Obstetrics and Gynecology 3 works
- 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Meizhou City People's Hospital's research output changed?
Output in 2018–2022 was 37% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Meizhou
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.